Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3733954016 | Product containing only nafarelin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3733955015 | Nafarelin only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2826271000001110 | Nafarelin (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2826281000001112 | Nafarelin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nafarelin | Has active ingredient | Nafarelin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Nafarelin | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Nafarelin | Is a | Product containing nafarelin | true | Inferred relationship | Existential restriction modifier | ||
| Nafarelin | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only nafarelin in nasal dose form (medicinal product form) | Is a | True | Nafarelin | Inferred relationship | Existential restriction modifier | |
| Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) | Is a | True | Nafarelin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR